Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials.
Saved in:
| Title: | Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials. |
|---|---|
| Authors: | Williams, H.1 (AUTHOR), Fokas, E.1,2,3,4,5,6 (AUTHOR), Diefenhardt, M.2,3,4,5 (AUTHOR), Lee, C.1 (AUTHOR), Verheij, F.S.1 (AUTHOR), Omer, D.M.1 (AUTHOR), Lin, S.T.7 (AUTHOR), Dunne, R.F.8 (AUTHOR), Marcet, J.9 (AUTHOR), Cataldo, P.10 (AUTHOR), Polite, B.11 (AUTHOR), Piso, P.12 (AUTHOR), Polat, B.13 (AUTHOR), Dapper, H.6 (AUTHOR), Ghadimi, M.14 (AUTHOR), Hofheinz, R.D.15 (AUTHOR), Qin, L.-X.7 (AUTHOR), Saltz, L.B.16 (AUTHOR), Wu, A.J.17 (AUTHOR), Gollub, M.J.18 (AUTHOR) |
| Source: | Annals of Oncology. May2025, Vol. 36 Issue 5, p543-547. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.01.006 |
